GB Sciences (GBLX) Stock Price, News & Analysis
Company Description
GB Sciences (OTC Link: GBLX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $122.1K.
GBLX has gained 200.0% over the past year. Shares last traded at $0.0003.
For FY2024, GB Sciences reported revenue of $0.
This page collects what Stock Titan holds for GBLX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
GB Sciences (GBLX) stock last closed at $0.0003. Over the past 12 months, the stock has gained 200.0%. At a market capitalization of $122.1K, GBLX is classified as a micro-cap stock with approximately 407.1M shares outstanding.
Latest News
GB Sciences has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include AI. View all GBLX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in GB Sciences (GBLX) currently stands at 10 shares, a new position with no short interest reported in the previous period. Since October 2025, short interest has decreased by 99.9%.
Days to Cover History
Days to cover for GB Sciences (GBLX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
GBLX Company Profile & Sector Positioning
GB Sciences (GBLX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GBLX often look at related companies in the same sector, including Adhera Therapeutics Inc (ATRX), U S Stem Cell Inc (USRM), Tracon Pharmaceu (TCON), Syros Pharmaceut (SYRS), and Aridis Pharmaceuticals Inc (ARDS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GBLX's relative position within its industry.